AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
Hisayuki Yao(Kyoto University Hospital), T Maekawa(Kyoto University Hospital)
Cited by 49
Related Papers
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
|Cell Death and Differentiation|2007|65
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment
|Cell Death and Differentiation|2010|38